These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20640899)

  • 61. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging--effect on observer performance.
    Hambrock T; Vos PC; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ
    Radiology; 2013 Feb; 266(2):521-30. PubMed ID: 23204542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diffusion-weighted MR imaging for assessing synovitis of wrist and hand in patients with rheumatoid arthritis: a feasibility study.
    Li X; Liu X; Du X; Ye Z
    Magn Reson Imaging; 2014 May; 32(4):350-3. PubMed ID: 24512797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?
    Hausmann D; Aksöz N; von Hardenberg J; Martini T; Westhoff N; Buettner S; Schoenberg SO; Riffel P
    Eur Radiol; 2018 Feb; 28(2):869-876. PubMed ID: 28799090
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diffusion-weighted imaging of prostate cancer.
    Shimofusa R; Fujimoto H; Akamata H; Motoori K; Yamamoto S; Ueda T; Ito H
    J Comput Assist Tomogr; 2005; 29(2):149-53. PubMed ID: 15772529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
    Rosenkrantz AB; Khalef V; Xu W; Babb JS; Taneja SS; Doshi AM
    Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
    Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
    Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study.
    Chong Y; Kim CK; Park SY; Park BK; Kwon GY; Park JJ
    AJR Am J Roentgenol; 2014 Apr; 202(4):772-7. PubMed ID: 24660705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
    Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
    Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study.
    Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
    Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis.
    Ning P; Shi D; Sonn GA; Vasanawala SS; Loening AM; Ghanouni P; Obara P; Shin LK; Fan RE; Hargreaves BA; Daniel BL
    Sci Rep; 2018 Feb; 8(1):3409. PubMed ID: 29467370
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.
    Barth BK; De Visschere PJL; Cornelius A; Nicolau C; Vargas HA; Eberli D; Donati OF
    Radiology; 2017 Sep; 284(3):725-736. PubMed ID: 28346073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer.
    Arita Y; Yoshida S; Waseda Y; Takahara T; Ishii C; Ueda R; Kwee TC; Miyahira K; Ishii R; Okuda S; Jinzaki M; Fujii Y
    Eur J Radiol; 2021 Apr; 137():109581. PubMed ID: 33578087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Restriction spectrum imaging improves MRI-based prostate cancer detection.
    McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
    Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.